Ritedose Opens New $17M cGMP Laboratory

The Ritedose Corporation has opened a new current Good Manufacturing Practice (cGMP) laboratory in South Carolina.

The more than $17 million investment in the new lab significantly expands Ritedose’s analytical chemistry and microbiology capabilities, tripling the Company’s laboratory footprint. Located inside the newest facility inside Ritedose Performance Park, the lab strengthens the Company’s ability to support pharmaceutical partners from early-stage development through commercial manufacturing, while expanding analytical services available to the broader life sciences community.

“This investment represents much more than additional lab space—it’s investing in the future of pharmaceutical innovation,” Ritedose president and CEO Jody Chastain said. “As therapies become increasingly complex, our customers need partners with sophisticated analytical capabilities, scientific expertise and the capacity to move swiftly. This facility enhances our ability to deliver all three while reinforcing our growing reputation as a destination for quality excellence and manufacturing innovation.”

A cornerstone of the expansion is Ritedose’s comprehensive stability program, which features 10 qualified ICH stability chambers supporting long-term, accelerated, intermediate, refrigerated and controlled room temperature studies, as well as freeze-thaw and photostability testing. Together, these capabilities provide pharmaceutical partners with the data needed to demonstrate product quality, performance and shelf life while supporting regulatory submissions and commercial product lifecycle management.

“Customers today expect a partner who can be there from start to finish. We have the people, the capabilities and the infrastructure to do that—and to do it right the first time, every time,” Chastain added.